Immediate Impact
11 from Science/Nature 55 standout
Citing Papers
Principles and therapeutic applications of adaptive immunity
2024 Standout
Designing antibodies as therapeutics
2022 Standout
Works of Kensuke Naito being referenced
Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers
2002
Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines
2000
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kensuke Naito | 617 | 653 | 300 | 50 | 1.1k | |
| Kaori Shinjo | 571 | 560 | 318 | 52 | 1.1k | |
| Randy A. Brown | 520 | 319 | 379 | 38 | 1.0k | |
| Satoki Nakamura | 239 | 583 | 210 | 65 | 986 | |
| Noriyoshi Iriyama | 412 | 307 | 254 | 82 | 915 | |
| Laura Cicconi | 419 | 647 | 113 | 32 | 889 | |
| Xun Cai | 392 | 856 | 94 | 37 | 1.1k | |
| Steven Novick | 625 | 806 | 423 | 28 | 1.4k | |
| Tiziana Grafone | 791 | 843 | 350 | 29 | 1.2k | |
| Miki Nishimura | 456 | 415 | 261 | 49 | 1.1k | |
| Nélida I. Noguera | 492 | 616 | 61 | 54 | 939 |
All Works
Loading papers...